Letter to the Editor Regarding &ldquo;Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study&rdquo; [Letter]

Chiara C Brück

doi:10.2147/NDT.S361484

open access to scientific and medical research

Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Letter

Letter to the Editor Regarding “Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study” [Letter]

Total article views		HTML views	PDF downloads	Totals
2,954	Dovepress*	2,905+	75	2,980
	PubMed Central*	49	14	63
	Totals	2,954	89	3,043
*Since 28 February 2022

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.